Method of treating difficult to access tumors with photoactivated cancer therapy
AssigneeImmunolight, LLC
InventorsFrederic A. BOURKE, Jr., Harold WALDER, Zakaryae FATHI
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunolight, LLC
InventorsFrederic A. BOURKE, Jr., Harold WALDER, Zakaryae FATHI
Estimating the term…
A system (and associated method) for treating a human or animal body. The system has a photoactivatable drug for treating a first diseased site, a first pharmaceutically acceptable carrier including one or more phosphorescent or fluorescent agents which are capable of emitting an activation energy into the body which activates the photoactivatable drug, a first device which infuses the first diseased site with a photoactivatable drug and the first pharmaceutically acceptable carrier, a first energy source which irradiates the diseased site with an initiation energy to thereby initiate emission of the activation energy into the body, and a supplemental treatment device which administers one or both of a therapeutic drug or radiation to the body at a second diseased site or the first diseased site, to provide an immune system stimulation in the body.
A method for treating a difficult to access/treat tumor in a subject, comprising:
Dependencies are inferred from the claim text.